메뉴 건너뛰기




Volumn 7, Issue 9, 2006, Pages 741-746

Response rate or time to progression as predictors of survival in trials of metastatic colorectal cancer or non-small-cell lung cancer: a meta-analysis

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; BEVACIZUMAB; CAPECITABINE; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; GEFITINIB; GEMCITABINE; HYDRAZINE SULFATE; IRINOTECAN; MATRIX METALLOPROTEINASE INHIBITOR; NAVELBINE; OXALIPLATIN; PACLITAXEL; THYMIDYLATE SYNTHASE INHIBITOR; TIRAPAZAMINE; VERAPAMIL;

EID: 33747844588     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(06)70800-2     Document Type: Article
Times cited : (164)

References (17)
  • 1
    • 0037108228 scopus 로고    scopus 로고
    • Policy developments in regulatory approval
    • Temple R. Policy developments in regulatory approval. Stat Med 21 (2002) 2939-2948
    • (2002) Stat Med , vol.21 , pp. 2939-2948
    • Temple, R.1
  • 3
    • 0027076295 scopus 로고
    • Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria
    • Green S., and Weiss G. Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria. Invest New Drugs 10 (1992) 239-253
    • (1992) Invest New Drugs , vol.10 , pp. 239-253
    • Green, S.1    Weiss, G.2
  • 4
    • 0034594628 scopus 로고    scopus 로고
    • New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
    • Therasse P., Arbuck S., Eisenhauer E., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 (2000) 205-216
    • (2000) J Natl Cancer Inst , vol.92 , pp. 205-216
    • Therasse, P.1    Arbuck, S.2    Eisenhauer, E.3
  • 5
    • 33747830466 scopus 로고    scopus 로고
    • Comparison of RECIST and WHO response criteria in metastatic colorectal carcinoma
    • Choi J., Ahn M., Rhim H., et al. Comparison of RECIST and WHO response criteria in metastatic colorectal carcinoma. J Clin Oncol 23 suppl (2005) 16S
    • (2005) J Clin Oncol , vol.23 , Issue.SUPPL
    • Choi, J.1    Ahn, M.2    Rhim, H.3
  • 7
    • 24644506259 scopus 로고    scopus 로고
    • Objective response rate as a surrogate end point: a commentary
    • Fleming T. Objective response rate as a surrogate end point: a commentary. J Clin Oncol 23 (2005) 4845-4846
    • (2005) J Clin Oncol , vol.23 , pp. 4845-4846
    • Fleming, T.1
  • 8
    • 33644834827 scopus 로고    scopus 로고
    • Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials
    • Sargent D., Wieand H., Haller D., et al. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 23 (2005) 8664-8670
    • (2005) J Clin Oncol , vol.23 , pp. 8664-8670
    • Sargent, D.1    Wieand, H.2    Haller, D.3
  • 9
    • 2542615200 scopus 로고    scopus 로고
    • Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
    • Andre T., Boni C., Mounedji-Boudiaf L., et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350 (2004) 2343-2351
    • (2004) N Engl J Med , vol.350 , pp. 2343-2351
    • Andre, T.1    Boni, C.2    Mounedji-Boudiaf, L.3
  • 11
    • 85047692188 scopus 로고
    • Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
    • Schulz K., Chalmers I., Hayes R., and Altman D. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273 (1995) 408-412
    • (1995) JAMA , vol.273 , pp. 408-412
    • Schulz, K.1    Chalmers, I.2    Hayes, R.3    Altman, D.4
  • 13
    • 33745203168 scopus 로고    scopus 로고
    • Burzykowski T., and Buyse M. (Eds). Burzykowski T., Molenberghs G., and Buyse M. (Eds), Springer, New York
    • In: Burzykowski T., and Buyse M. (Eds). An alternative measure for meta-analytic surrogate endpoint validation. In: Burzykowski T., Molenberghs G., and Buyse M. (Eds). The evaluation of surrogate endpoints (2005), Springer, New York
    • (2005) The evaluation of surrogate endpoints
  • 14
    • 33748086937 scopus 로고    scopus 로고
    • The evaluation of surrogate endpoints in practice: experience in HIV
    • Burzykowski T., Molenberghs G., and Buyse M. (Eds), Springer, New York
    • Hughes M. The evaluation of surrogate endpoints in practice: experience in HIV. In: Burzykowski T., Molenberghs G., and Buyse M. (Eds). The evaluation of surrogate endpoints (2005), Springer, New York
    • (2005) The evaluation of surrogate endpoints
    • Hughes, M.1
  • 15
    • 0034729931 scopus 로고    scopus 로고
    • Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Meta-Analysis Group in Cancer
    • Buyse M., Thirion P., Carlson R., et al. Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Meta-Analysis Group in Cancer. Lancet 356 (2000) 373-378
    • (2000) Lancet , vol.356 , pp. 373-378
    • Buyse, M.1    Thirion, P.2    Carlson, R.3
  • 16
    • 24644440601 scopus 로고    scopus 로고
    • Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients
    • Bruzzi P., Del Mastro L., Sormani M., et al. Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients. J Clin Oncol 23 (2005) 5117-5125
    • (2005) J Clin Oncol , vol.23 , pp. 5117-5125
    • Bruzzi, P.1    Del Mastro, L.2    Sormani, M.3
  • 17
    • 0037083255 scopus 로고    scopus 로고
    • Individual patient-versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head
    • Berlin J., Santanna J., Schmid C., et al. Individual patient-versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med 21 (2002) 371-387
    • (2002) Stat Med , vol.21 , pp. 371-387
    • Berlin, J.1    Santanna, J.2    Schmid, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.